For healthcare providers, the landscape of opioid prescribing continues to be high-risk and highly scrutinized. Over the past several years, our Health Care Advisory Team has represented physicians facing investigations and disciplinary action under the Missouri Medical Practice Act for their prescribing practices.
In our latest article, “Lessons Learned from Defending Medical Licenses against Opioid Claims,” attorney Michael R. Barth shares practical insights and key strategies we’ve developed while defending these cases — from the importance of pain management contracts and urine drug screens to understanding Morphine Milligram Equivalents (MME) and the evolving influence of CDC guidelines.
Whether you’re a provider, compliance officer, or legal advisor in the healthcare space, this piece offers a detailed look at how regulatory expectations are being applied — and how to stay on the right side of them.
Read the full article click here.